Secreted fungal virulence effector triggers allergic inflammation via TLR4.
Nature
; 608(7921): 161-167, 2022 08.
Article
en En
| MEDLINE
| ID: mdl-35896747
Invasive fungal pathogens are major causes of human mortality and morbidity1,2. Although numerous secreted effector proteins that reprogram innate immunity to promote virulence have been identified in pathogenic bacteria, so far, there are no examples of analogous secreted effector proteins produced by human fungal pathogens. Cryptococcus neoformans, the most common cause of fungal meningitis and a major pathogen in AIDS, induces a pathogenic type 2 response characterized by pulmonary eosinophilia and alternatively activated macrophages3-8. Here, we identify CPL1 as an effector protein secreted by C. neoformans that drives alternative activation (also known as M2 polarization) of macrophages to enable pulmonary infection in mice. We observed that CPL1-enhanced macrophage polarization requires Toll-like receptor 4, which is best known as a receptor for bacterial endotoxin but is also a poorly understood mediator of allergen-induced type 2 responses9-12. We show that this effect is caused by CPL1 itself and not by contaminating lipopolysaccharide. CPL1 is essential for virulence, drives polarization of interstitial macrophages in vivo, and requires type 2 cytokine signalling for its effect on infectivity. Notably, C. neoformans associates selectively with polarized interstitial macrophages during infection, suggesting a mechanism by which C. neoformans generates its own intracellular replication niche within the host. This work identifies a circuit whereby a secreted effector protein produced by a human fungal pathogen reprograms innate immunity, revealing an unexpected role for Toll-like receptor 4 in promoting the pathogenesis of infectious disease.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Proteínas Fúngicas
/
Criptococosis
/
Cryptococcus neoformans
/
Factores de Virulencia
/
Receptor Toll-Like 4
/
Hipersensibilidad
/
Inflamación
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Nature
Año:
2022
Tipo del documento:
Article